Reporter Sept 23 2016
Sep. 22, 2016—The Vanderbilt Transplant Center, one of the largest organ transplant programs in the Southeast, has not only surpassed the projected number of transplants it expected to perform for fiscal year (FY) 2016, but also experienced an increase in the total number of transplants performed over the previous year.
Sep. 22, 2016—Under the sweeping technology initiative called EpicLeap, Vanderbilt University Medical Center is on course to replace the greater part of its clinical, billing and administrative software by November 2017, with an eye to improving continuity of care, efficiency and patient and care-team experiences.
Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.
Sep. 22, 2016—Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research.
Sep. 22, 2016—Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.
Sep. 22, 2016—Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients.
Sep. 22, 2016—Jeffrey Creasy, M.D., chief of Neuroradiology in Vanderbilt’s Department of Radiology and Radiological Sciences, recently participated in a three-week American Society of Neuroradiology (ASNR) International Outreach Professorship to South Africa.